Reticulose

Re`tic´u`lose`


a.1.Forming a network; characterized by a reticulated sructure.
Reticulose rhizopod
(Zool.) a rhizopod in which the pseudopodia blend together and form irregular meshes.
Mentioned in ?
References in periodicals archive ?
Two other phyla with many amoebae (Amoebozoa, typically with lobose pseudopods; and Cercozoa (1, 5) with usually filose or reticulose pseudopods) also include some zooflagellates.
One, United States Patent 5,807,839 titled, "A Method for Stimulating Red Blood Cell Production," describes a use of one of the stimulation effects of Reticulose on bone marrow.
Originally, he began work on the concept of a peptide-nucleic acid solution, known as Reticulose, in 1965 as the Assistant Medical Director of Key Pharmaceuticals, Inc.
The patients in the Reticulose test group also gained weight and experienced an improved clinical condition, compared with the control group.
OTC BB:ADVR) announced Thursday that its scientists have discovered that its lead antiviral drug, Reticulose, inhibited the production of a key cellular receptor for HIV.
The financing, in the amount of $3 million (gross), will be used to help fund the company's ongoing research and development program for its drug RETICULOSE, as well as the appointment of qualified scientists and initiating the formal process for seeking governmental approvals to market RETICULOSE.
Flichman in connection with an open label clinical trial assessing the efficacy and safety of ADVR's drug Reticulose on the human papilloma virus (genital warts).
The letter states that reticulose is completely safe to use in "topic application.
Further, Reticulose stimulates production of a unique set of Chemokines, including Interleukin 6 and Gamma Interferon.
OTC:ADVR) announced today that an open label trial on 20 human patients to assess the efficacy of the company's drug Reticulose on the Human Papilloma Virus (HPV) began on April 15, 1996.
OTC:ADVR) enters into exclusive distribution agreement to distribute the anti-viral drug RETICULOSE in the People's Republic of China with Beijing Unistone Pharmaceutical Co.
the "company") (BB:ADVR), incorporated under the laws of the State of Delaware on July 31, 1985, was organized to engage in the production and marketing, promotion and sale of a non-toxic, anti-viral peptide-nucleic acid complex solution with the trade name RETICULOSE.